Fluid Challenge Infusion and Response
Launched by HUMANITAS CLINICAL AND RESEARCH CENTER · Jan 16, 2019
Trial Information
Current as of August 19, 2025
Completed
Keywords
ClinConnect Summary
Dedicated algorithms and protocols of anaesthetic care regarding fluid therapy are key factors to prevent perioperative hypovolaemia and/or hypervolemia, which are known to increase morbidity and length of hospital stay.
Fluid therapy is commonly used in critically ill and surgical patients to restore hemodynamics. The aim of volume expansion is to increase cardiac index and oxygen delivery and to improve tissue oxygenation. However, this occurs only in a situation of preload dependency (i.e. when the ventricle operates on the steep part of the Frank-Starling's curve). Moreover, giving flu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients aged ≥ 18 years;
- • 2. Scheduled for elective supine neurosurgery and requiring invasive arterial monitoring;
- • 3. Glasgow coma scale 15 at recruitment
- Exclusion Criteria:
- • 1. Any recurrent cardiac arrhythmias;
- • 2. Reduced left (ejection fraction \<30%) or right (systolic peak velocity of tricuspid annular motion \<0.17 m/s) ventricular systolic function;
- • 3. Intra-operative use of vasopressors or inotropes before FC administration or between the first and the second bolus of fluids.
- • 4. Chronic use beta-blocking agents.
About Humanitas Clinical And Research Center
Humanitas Clinical and Research Center is a leading institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Located in Italy, the center specializes in conducting high-quality clinical trials across various therapeutic areas, including oncology, cardiology, and neurology. With a commitment to scientific excellence and ethical standards, Humanitas collaborates with academic institutions, pharmaceutical companies, and healthcare organizations to foster groundbreaking discoveries and improve patient outcomes. The center's multidisciplinary team of experts leverages state-of-the-art facilities and cutting-edge technologies to ensure rigorous study design and execution, ultimately contributing to the advancement of medical knowledge and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rozzano, Milano, Italy
Rozzano, Lombardia, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials